TRPV4 and Hepatic fibrosis: Using a mouse model of CCl4-induced liver fibrosis, Fu and colleagues employed the TRPV4 agonist GSK1016790A and inhibitor HC-067,047 in order to activate and inhibit, respectively, TRPV4.